FDA Approves Generic Of GSK Flonase But Launch Halted By Restraining Order
Executive Summary
FDA's approval of generic Flonase has prompted a lawsuit by GlaxoSmithKline representing another challenge by brand manufacturers to the legitimacy of FDA-approved generic drugs
You may also be interested in...
Industry/Agency Revolving Door Hits Spear In Nose, But Firm Relaunches ANDA
While Spear's generic fluorouracil is back on the market after a temporary restraining order expired June 18, the odyssey illustrates the risks to companies inherent in FDA relying on industry opinions during product review
Is FDA Less Confident In ANDAs? Stay On Efudex Generic May Set Precedent
FDA's decision to review its approval of a generic for Valeant's topical Efudex (fluorouracil) Cream 5% may create a precedent for future approvals of ANDAs for complex small molecule drugs and could set the stage for higher hurdles for eventual approvals of biogenerics
Is FDA Less Confident In ANDAs? Stay On Efudex Generic May Set Precedent
FDA's decision to review its approval of a generic for Valeant's topical Efudex (fluorouracil) Cream 5% may create a precedent for future approvals of ANDAs for complex small molecule drugs and could set the stage for higher hurdles for eventual approvals of biogenerics